amsacrine , 90 mg/m2 , was given daily for 5-8 days to 45 patients with acute myeloblastic leukemia , 15 patients with acute lymphoblastic leukemia , and six patients with blastic transformation of chronic granulocytic leukemia .
C0023467
acute
C0023479
blastic